Skip to content
September 28, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Popular Tags
  • Patient Advocacy and Support
  • Medical Research and Clinical Trials
  • Treatment Innovations
  • Genomics and Precision Medicine
  • Survivorship and Post-Treatment
  • Integrative Oncology and Holistic Care
  • Chemotherapy and Targeted Therapy
  • Global Breast Cancer Awareness
  • Breast Cancer Legislation and Policy
  • Breast Cancer Surgery and Reconstruction
Breaking News
economic-anxiety-and-political-divergence-a-deep-dive-into-the-2026-kff-ap-rural-voters-survey Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey unnamed-file cambridge-breakthrough-heralds-new-era-for-aggressive-inherited-breast-cancers-100-survival-rate-achieved-in-landmark-trial Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial sofinnova-partners-accelerates-medtech-innovation-with-e82m-md-start-iv-fund Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund a-triumph-of-resilience-timor-leste-achieves-historic-malaria-free-status A Triumph of Resilience: Timor-Leste Achieves Historic Malaria-Free Status

Main News

economic-anxiety-and-political-divergence-a-deep-dive-into-the-2026-kff-ap-rural-voters-survey
  • Breast Cancer Legislation and Policy

Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey

Asep Darmawan September 28, 2026
unnamed-file
  • Integrative Oncology and Holistic Care

Siti Muinah September 28, 2026
cambridge-breakthrough-heralds-new-era-for-aggressive-inherited-breast-cancers-100-survival-rate-achieved-in-landmark-trial
  • Medical Research and Clinical Trials

Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial

Laily UPN September 28, 2026
sofinnova-partners-accelerates-medtech-innovation-with-e82m-md-start-iv-fund
  • Treatment Innovations

Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund

Siti Muinah September 28, 2026
a-triumph-of-resilience-timor-leste-achieves-historic-malaria-free-status
  • Breast Cancer Prevention and Lifestyle

A Triumph of Resilience: Timor-Leste Achieves Historic Malaria-Free Status

Layla Zulfa September 28, 2026
  • Recommended
  • Popular
  • Archive
  • Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey economic-anxiety-and-political-divergence-a-deep-dive-into-the-2026-kff-ap-rural-voters-survey
    • Breast Cancer Legislation and Policy

    Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey

    Asep Darmawan September 28, 2026
  • unnamed-file
    • Integrative Oncology and Holistic Care

    Siti Muinah September 28, 2026
  • Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial cambridge-breakthrough-heralds-new-era-for-aggressive-inherited-breast-cancers-100-survival-rate-achieved-in-landmark-trial
    • Medical Research and Clinical Trials

    Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial

    Laily UPN September 28, 2026
  • Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund sofinnova-partners-accelerates-medtech-innovation-with-e82m-md-start-iv-fund
    • Treatment Innovations

    Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund

    Siti Muinah September 28, 2026
  • unnamed-file
    • Integrative Oncology and Holistic Care

    Siti Muinah September 28, 2026
  • Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day® beyond-the-diagnosis-uniting-the-world-for-the-39th-national-cancer-survivors-day
    • Survivorship and Post-Treatment

    Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day®

    Lina Irawan May 8, 2026 0
  • Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients detalimogene-voraplasmid-shows-promising-efficacy-and-tolerability-in-bcg-unresponsive-nmibc-offering-new-hope-for-patients
    • Medical Research and Clinical Trials

    Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients

    Lina Irawan May 9, 2026 0
  • A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer a-paradigm-shift-in-oncology-nccn-guidelines-embrace-ai-to-predict-not-just-detect-breast-cancer
    • Patient Advocacy and Support

    A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer

    Lina Irawan May 9, 2026 0
  • Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey economic-anxiety-and-political-divergence-a-deep-dive-into-the-2026-kff-ap-rural-voters-survey
    • Breast Cancer Legislation and Policy

    Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey

    Asep Darmawan September 28, 2026
  • unnamed-file
    • Integrative Oncology and Holistic Care

    Siti Muinah September 28, 2026
  • Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial cambridge-breakthrough-heralds-new-era-for-aggressive-inherited-breast-cancers-100-survival-rate-achieved-in-landmark-trial
    • Medical Research and Clinical Trials

    Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial

    Laily UPN September 28, 2026
  • Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund sofinnova-partners-accelerates-medtech-innovation-with-e82m-md-start-iv-fund
    • Treatment Innovations

    Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund

    Siti Muinah September 28, 2026

Featured News

economic-anxiety-and-political-divergence-a-deep-dive-into-the-2026-kff-ap-rural-voters-survey
  • Breast Cancer Legislation and Policy

Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey

Asep Darmawan September 28, 2026
unnamed-file
  • Integrative Oncology and Holistic Care

Siti Muinah September 28, 2026
cambridge-breakthrough-heralds-new-era-for-aggressive-inherited-breast-cancers-100-survival-rate-achieved-in-landmark-trial
  • Medical Research and Clinical Trials

Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial

Laily UPN September 28, 2026
sofinnova-partners-accelerates-medtech-innovation-with-e82m-md-start-iv-fund
  • Treatment Innovations

Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund

Siti Muinah September 28, 2026

General

Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey economic-anxiety-and-political-divergence-a-deep-dive-into-the-2026-kff-ap-rural-voters-survey
  • Breast Cancer Legislation and Policy

Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey

Asep Darmawan September 28, 2026
unnamed-file
  • Integrative Oncology and Holistic Care

Siti Muinah September 28, 2026
Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial cambridge-breakthrough-heralds-new-era-for-aggressive-inherited-breast-cancers-100-survival-rate-achieved-in-landmark-trial
  • Medical Research and Clinical Trials

Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial

Laily UPN September 28, 2026
Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund sofinnova-partners-accelerates-medtech-innovation-with-e82m-md-start-iv-fund
  • Treatment Innovations

Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund

Siti Muinah September 28, 2026

Opinion

Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey economic-anxiety-and-political-divergence-a-deep-dive-into-the-2026-kff-ap-rural-voters-survey
  • Breast Cancer Legislation and Policy

Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey

Asep Darmawan September 28, 2026
unnamed-file
  • Integrative Oncology and Holistic Care

Siti Muinah September 28, 2026
Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial cambridge-breakthrough-heralds-new-era-for-aggressive-inherited-breast-cancers-100-survival-rate-achieved-in-landmark-trial
  • Medical Research and Clinical Trials

Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial

Laily UPN September 28, 2026
Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund sofinnova-partners-accelerates-medtech-innovation-with-e82m-md-start-iv-fund
  • Treatment Innovations

Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund

Siti Muinah September 28, 2026

More

Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey economic-anxiety-and-political-divergence-a-deep-dive-into-the-2026-kff-ap-rural-voters-survey
  • Breast Cancer Legislation and Policy

Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey

Asep Darmawan September 28, 2026
unnamed-file
  • Integrative Oncology and Holistic Care

Siti Muinah September 28, 2026
Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial cambridge-breakthrough-heralds-new-era-for-aggressive-inherited-breast-cancers-100-survival-rate-achieved-in-landmark-trial
  • Medical Research and Clinical Trials

Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial

Laily UPN September 28, 2026
Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund sofinnova-partners-accelerates-medtech-innovation-with-e82m-md-start-iv-fund
  • Treatment Innovations

Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund

Siti Muinah September 28, 2026
Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey economic-anxiety-and-political-divergence-a-deep-dive-into-the-2026-kff-ap-rural-voters-survey
  • Breast Cancer Legislation and Policy

Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey

Asep Darmawan September 28, 2026
As the United States hurtles toward the 2026 midterm elections, a new comprehensive study from KFF and...
Read More Read more about Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey
unnamed-file
  • Integrative Oncology and Holistic Care

Siti Muinah September 28, 2026
Read More Read more about
Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial cambridge-breakthrough-heralds-new-era-for-aggressive-inherited-breast-cancers-100-survival-rate-achieved-in-landmark-trial
  • Medical Research and Clinical Trials

Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial

Laily UPN September 28, 2026
CAMBRIDGE, UK – In a monumental stride for cancer treatment, Cambridge researchers have unveiled a groundbreaking approach...
Read More Read more about Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial
Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund sofinnova-partners-accelerates-medtech-innovation-with-e82m-md-start-iv-fund
  • Treatment Innovations

Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund

Siti Muinah September 28, 2026
In a move that signals robust confidence in the European and American life sciences ecosystem, Sofinnova Partners...
Read More Read more about Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund
A Triumph of Resilience: Timor-Leste Achieves Historic Malaria-Free Status a-triumph-of-resilience-timor-leste-achieves-historic-malaria-free-status
  • Breast Cancer Prevention and Lifestyle

A Triumph of Resilience: Timor-Leste Achieves Historic Malaria-Free Status

Layla Zulfa September 28, 2026
In a landmark achievement for global public health, the World Health Organization (WHO) has officially certified Timor-Leste...
Read More Read more about A Triumph of Resilience: Timor-Leste Achieves Historic Malaria-Free Status
A Titan of Global Health: Remembering the Extraordinary Life and Legacy of Dr. David Nabarro a-titan-of-global-health-remembering-the-extraordinary-life-and-legacy-of-dr-david-nabarro
  • Global Breast Cancer Awareness

A Titan of Global Health: Remembering the Extraordinary Life and Legacy of Dr. David Nabarro

Nila Kartika Wati September 28, 2026
The global health community is in mourning following the passing of Dr. David Nabarro, a visionary leader,...
Read More Read more about A Titan of Global Health: Remembering the Extraordinary Life and Legacy of Dr. David Nabarro
Navigating Chemotherapy-Induced Hair Loss: A Comprehensive Guide to Wigs and Self-Empowerment navigating-chemotherapy-induced-hair-loss-a-comprehensive-guide-to-wigs-and-self-empowerment-1
  • Survivorship and Post-Treatment

Navigating Chemotherapy-Induced Hair Loss: A Comprehensive Guide to Wigs and Self-Empowerment

Siti Muinah September 28, 2026
For many individuals undergoing cancer treatment, hair loss represents far more than a simple aesthetic change. It...
Read More Read more about Navigating Chemotherapy-Induced Hair Loss: A Comprehensive Guide to Wigs and Self-Empowerment
A New Dawn for Genetic Medicine: Casgevy Now Available on the NHS a-new-dawn-for-genetic-medicine-casgevy-now-available-on-the-nhs
  • Genomics and Precision Medicine

A New Dawn for Genetic Medicine: Casgevy Now Available on the NHS

Pevita Pearce September 28, 2026
In a landmark development for precision medicine, the NHS in England has officially rolled out Casgevy—the world’s...
Read More Read more about A New Dawn for Genetic Medicine: Casgevy Now Available on the NHS
Multiple Myeloma Landscape Heats Up: Key Data from IMS 2026 Ignites Pharma Battle multiple-myeloma-landscape-heats-up-key-data-from-ims-2026-ignites-pharma-battle
  • Medical Research and Clinical Trials

Multiple Myeloma Landscape Heats Up: Key Data from IMS 2026 Ignites Pharma Battle

Lina Irawan September 28, 2026
Glasgow, Scotland – September 28, 2026 – The International Myeloma Society (IMS) 2026 Congress, held in Glasgow...
Read More Read more about Multiple Myeloma Landscape Heats Up: Key Data from IMS 2026 Ignites Pharma Battle
From Bench to Bedside: The Operational Imperative in the New Era of Biopharma from-bench-to-bedside-the-operational-imperative-in-the-new-era-of-biopharma
  • Treatment Innovations

From Bench to Bedside: The Operational Imperative in the New Era of Biopharma

Asep Darmawan September 28, 2026
For decades, the narrative of the biopharmaceutical industry has been dominated by the “breakthrough”: the discovery of...
Read More Read more about From Bench to Bedside: The Operational Imperative in the New Era of Biopharma

Posts pagination

1 2 3 4 … 631 Next

Recent Posts

  • Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey
  • (no title)
  • Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial
  • Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund
  • A Triumph of Resilience: Timor-Leste Achieves Historic Malaria-Free Status

Recent Comments

No comments to show.

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

economic-anxiety-and-political-divergence-a-deep-dive-into-the-2026-kff-ap-rural-voters-survey
  • Breast Cancer Legislation and Policy

Economic Anxiety and Political Divergence: A Deep Dive into the 2026 KFF/AP Rural Voters Survey

Asep Darmawan September 28, 2026
unnamed-file
  • Integrative Oncology and Holistic Care

Siti Muinah September 28, 2026
cambridge-breakthrough-heralds-new-era-for-aggressive-inherited-breast-cancers-100-survival-rate-achieved-in-landmark-trial
  • Medical Research and Clinical Trials

Cambridge Breakthrough Heralds New Era for Aggressive Inherited Breast Cancers: 100% Survival Rate Achieved in Landmark Trial

Laily UPN September 28, 2026
sofinnova-partners-accelerates-medtech-innovation-with-e82m-md-start-iv-fund
  • Treatment Innovations

Sofinnova Partners Accelerates Medtech Innovation with €82M ‘MD Start IV’ Fund

Siti Muinah September 28, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.